(−)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation

Gupta, 2003, Molecular pathway for (−)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells, Arch Biochem Biophys, 410, 177, 10.1016/S0003-9861(02)00668-9 Lu, 2002, Topical applications of caffeine or (−)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice, Proc Natl Acad Sci USA, 99, 12455, 10.1073/pnas.182429899 Witschi, 2004, Chemoprevention of tobacco smoke-induced lung tumors by inhalation of an epigallocatechin gallate (EGCG) aerosol: a pilot study, Inhal Toxicol, 16, 763, 10.1080/08958370490490400 Beltz, 2006, Mechanisms of cancer prevention by green and black tea polyphenols, Anticancer Agents Med Chem, 6, 389, 10.2174/187152006778226468 Khan, 2006, Targeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallate, Cancer Res, 66, 2500, 10.1158/0008-5472.CAN-05-3636 Laschke, 2008, Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo, Hum Reprod, 23, 2308, 10.1093/humrep/den245 Zhang, 2010, Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice, Am J Obstet Gynecol, 202, 289.e1, 10.1016/j.ajog.2009.10.885 Zhang, 2010, Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells, Fertil Steril, 5, 1887, 10.1016/j.fertnstert.2009.08.065 Jemal, 2008, Cancer statistics, CA Cancer J Clin, 58, 71, 10.3322/CA.2007.0010 American Cancer Society. Estimated new cancer cases and deaths by sex, US, 2009. Available at http://www.cancer.org/acs/groups/content/@nho/ documents/document/500809webpdf.pdf, page 4, accessed September 7, 2010. Lian, 2001, Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice, Jpn J Cancer Res, 92, 726, 10.1111/j.1349-7006.2001.tb01154.x Lian, 2004, Soybean isoflavones inhibit estrogen-stimulated gene expression in mouse uteri, Eur J Gynaecol Oncol, 25, 311 Dann, 2009, Regulation of vascular endothelial growth factor in endometrial tumour cells by resveratrol and EGCG, Gynecol Oncol, 113, 374, 10.1016/j.ygyno.2009.02.014 Fatima, 2012, 2,3-Diaryl-2H-1-benzopyran derivatives interfere with classical and non-classical estrogen receptor signaling pathways, inhibit Akt activation and induce apoptosis in human endometrial cancer cells, Mol Cell Endocrinol, 348, 198, 10.1016/j.mce.2011.08.018 Jos, 2009, The antioxidant glutathione in the fish cell lines EPC and BCF-2: response to model pro-oxidants as measured by three different fluorescent dyes, Toxicol In Vitro, 23, 546, 10.1016/j.tiv.2009.01.013 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Delneste, 1997, N-acetyl-l-cysteine exhibits antitumoral activity by increasing tumor necrosis factor alpha-dependent T-cell cytotoxicity, Blood, 90, 1124, 10.1182/blood.V90.3.1124 Heyninck, 1999, Inhibition of tumor necrosis factor-induced necrotic cell death by the zinc finger protein A20, Anticancer Res, 19, 2863 Johnson, 2002, Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p-38 protein kinases, Science, 298, 1911, 10.1126/science.1072682 Sartippour, 2001, Green tea and its catechins inhibit breast cancer xenografts, Nutr Cancer, 40, 149, 10.1207/S15327914NC402_11 Masuda, 2001, Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines, Clin Cancer Res, 7, 4220 Kim, 2005, (−)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells, Carcinogenesis, 26, 1553, 10.1093/carcin/bgi104 Hou, 2005, Mechanism of action of (−)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells, Cancer Res, 65, 10.1158/0008-5472.CAN-05-0480 Sexton, 2006, Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells, Mol Cancer, 17, 45, 10.1186/1476-4598-5-45 Simbula, 2007, Increased ROS generation and p53 activation in α-lipoic acid-induced apoptosis of hepatoma cells, Apoptosis, 12, 113, 10.1007/s10495-006-0487-9 Jaganathan, 2010, Involvement of non-protein thiols, mitochondrial dysfunction, reactive oxygen species and p53 in honey-induced apoptosis, Invest New Drugs, 28, 624, 10.1007/s10637-009-9302-0 Shi, 2000, Antioxidant properties of (−)-epicatechin-3-gallate and its inhibition of Cr (VI)-induced DNA damage and Cr (IV)- or TPA-stimulated NF-kappaB activation, Mol Cell Biochem, 206, 125, 10.1023/A:1007012403691 Azam, 2007, Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties, Toxicol In Vitro, 18, 555, 10.1016/j.tiv.2003.12.012 Zu, 2005, Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by alphatocopheryl succinate in human prostate cancer cells, Mol Cancer Ther, 4, 43, 10.1186/1476-4598-4-43 Iwamaru, 2007, Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonianoctocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway, Mol Cancer Ther, 6, 184, 10.1158/1535-7163.MCT-06-0422 Cotgreave, 1997, N-acetylcysteine: pharmacological considerations and experimental and clinical applications, Adv Pharmacol, 38, 205, 10.1016/S1054-3589(08)60985-0 Wang, 2009, The effects of green tea ( − )-epigallocatechin-3-gallate on reactive oxygen species in 3T3-L1preadipocyt es and adipocytes depend on the glutathione and 67 kDa laminin receptor pathways, Mol Nutr Food Res, 53, 349, 10.1002/mnfr.200800013 Leopold, 2000, Development of anticancer drugs targeting the MAP kinase pathway, Oncogene, 19, 6594, 10.1038/sj.onc.1204083 Lau, 2010, Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells, Br J Cancer, 102, 583, 10.1038/sj.bjc.6605487 Xia, 1995, Opposing effects of ERK and JNK-p3 8 MAP kinases on apoptosis, Science, 270, 1326, 10.1126/science.270.5240.1326 Konishi, 1999, Activation of protein kinase induced by H(2)O(2) and heat shock through distinct mechanisms dependent and independent of phosphatidyl-inositol 3-kinase, J Biochem, 126, 1136, 10.1093/oxfordjournals.jbchem.a022559 Wang, 2000, Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival, J Biol Chem, 275, 14624, 10.1074/jbc.275.19.14624 Hyun, 2010, BBR induces apoptosis in HepG2 cell through an Akt-ASK1-ROS-p38MAPKs-linked cascade, J Cell Biochem, 109, 329 Saeki, 2002, Biochem J, 368, 705, 10.1042/bj20020101